Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? is a research paper published in Open Forum Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HHSN266200700023C [N01-AI-70023]
National Heart, Lung, and Blood Institute
Grant: 2U10 HL069301-11
National Heart, Lung, and Blood Institute
Grant: UO1 HL69301
National Cancer Institute
Grant: U10HL069294
NHLBI NIH HHS
Grant: U01 HL069301
NHLBI NIH HHS
Grant: UG1 HL069301
NIAID NIH HHS
Grant: N01 AI070023
NHLBI NIH HHS
Grant: U10 HL069301
NHLBI NIH HHS
Grant: UG1 HL069249
National Institute of Allergy and Infectious Diseases
Pfizer Inc.
Keywords